Walgreens Q2 2016 Earnings Review: Acquisition Synergies To Boost Margins Going Forward

73.99
Trefis
WAG: Walgreen logo
WAG
Walgreen

Walgreens (NASDAQ:WBA), one of the largest pharmacies in the US released its Q2 2016 earnings on April 5th. (Fiscal years end with August.) The company reported a strong quarter driven by the acquisition of Alliance Boots and growth in Medicare Part D prescriptions . Following is a brief look at the numbers and trends that drove WBA’s performance in the second quarter.

wba-e-1 wba-e-2
wba-e-3

 

Relevant Articles
  1. Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs of $185?
  2. Should You Pick Eli Lilly Stock After A 4x Rise In Three Years?
  3. Down 9% This Year, What’s Next For Lululemon’s Stock Past Q4 Results?
  4. Down 14% In The Last Trading Session, Where Is Adobe Stock Headed?
  5. Will Higher Federal Government Spending, Gen AI Drive Digital Security Stocks Like CrowdStrike Higher?
  6. Up 30% In A Year Is FedEx Stock A Better Pick Over UPS?

Factors That Will Drive Growth Going Forward

  • Rite Aid’s acquisition (expected completion in second half of 2016) will add to the Retail Pharmacy USA business and help grow WBA’s market share
  • High Comparable store sales will continue to positively impact revenues driven by the growing Medicare Part D priscriptions
  • International Pharmacy and Pharmaceutical Wholesale business will continue to grow
  • Higher synergy benefits expected from AmerisouceBergen and refinancing Alliance Boots Indebtedness at a lower cost

Offsetting Factor

  • Generic Drugs will continue to adversely impact revenues

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com.
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our analysis for Walgreens

View Interactive Institutional Research (Powered by Trefis):

Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap

More Trefis Research